The world's leading pharmaceutical companies will on Thursday undertake to publish more data about clinical trials of their drugs, in an effort to reassure patients about the safety of their medicines.

The move, which is also designed to head off legislation demanding disclosure, comes as fresh allegations surface that US scientists manipulated trials of an anti-Aids drug in order to make it seem more effective, thereby endangering of patients.